As the lead investor in NewLeaf Symbiotics, Open Prairie can wholeheartedly attest that the progress made to date by NewLeaf Symbiotics is largely attributable to the key infrastructure components and intellectual capital made available by the Donald Danforth Plant Science Center and BRDG Park.
These organizations have played a major role in all aspects of the organization. Two Danforth Center scientists sit on NewLeaf’s Advisory Board providing invaluable guidance on technology development and prior to Series A funding, NewLeaf used interns and lab equipment from St. Louis Community College at BRDG Park.
With the Series A financing, NewLeaf was able to secure their own equipment and lab space at BRDG Park, hire several interns as full-time team members and began utilizing the state-of-the-art greenhouses at the Danforth Center for trials.
Additionally, NewLeaf’s acquisition of Intuitive Genomics was facilitated by a collaborative relationship that was developed through connections with the Danforth Center and BRDG Park.
Due to their rapid growth, NewLeaf has been able to attract leading research scientists and product development talent not only from St. Louis but also from outside the region to relocate to St. Louis. The company has also recently tripled the size of their offices and lab space at BRDG Park.
As NewLeaf advances towards commercialization of its technology, the agricultural infrastructure in the St. Louis region and the leadership provided by the Danforth Center and BRDG Park will continue to play a critical role in NewLeaf’s mission to build one of the world’s leading agricultural biotechnology companies.
About NewLeaf Symbiotics
NewLeaf is a venture-backed agricultural biotech company that is researching and commercializing beneficial plant bacteria for crop growth, health, and protection. NewLeaf is based in St. Louis and was founded by a group of entrepreneurs and former Monsanto scientists and executives. In December 2013 NewLeaf announced the acquisition of Intuitive Genomics, a leading genomics and bioinformatics company. Investors in NewLeaf include Rockport Capital, Open Prairie Ventures, and Pangaea Ventures. More information is available at www.newleafsym.com